Our Chowder Rule calculator helps you avoid low-yield stocks with weak growth and high-yield stocks whose dividend growth is too slow to support strong long-term compounding.
Source link
Register for a Free Live Training The Hot Stocks Outlook uses VantagePoint’s market forecasts that are up to 87.4% accurate, demonstrating how traders can improve their timing and direction. In this week’s video, VantagePoint Software reviews forecasts for SPDR SPY($SPY), GE Aerospace ($GE), HUMANA ($HUM), Seagate Technology ($STX), APPLE ($AAPL), Las Vegas Sands ($LVS), CDW…
This article was written by Follow I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct…
Are you a retiree looking for dependable passive income? Or an investor who wants your investments to generate cash flow to cover monthly expenses? The “money laddering” strategy is a simple, structured way to achieve this goal by creating predictable, repeating cash flow. View the CNA Money Mind: Cash Flow Generation using Laddering Strategy. What is a Money…
Axis Securities has set a target price of Rs 2,500 on Lupin, showing an upside potential of around 27% from the current market prices. “New launches in the U.S. market, such as Darunavir and Spiriva, have gained market shares of up to 30% and 25%, respectively. The recent approval for gMegabran has the potential to…
by Calculated Risk on 7/31/2025 02:42:00 PM The U.S. hotel industry reported negative year-over-year comparisons, according to CoStar’s latest data through 26 July. … 20-26 July 2025 (percentage change from comparable week in 2024): • Occupancy: 71.5% (-0.7%)• Average daily rate (ADR): US$164.88 (-0.1%)• Revenue per available room (RevPAR): US$117.88 (-0.8%)emphasis added The following graph…
Morsa Images As Generative AI impacts drug research, this thesis aims to uncover the opportunities for Exscientia plc (NASDAQ:EXAI) and show it is a buy based on the strength of its technology platform. Noteworthily, I was again bullish when covering the stock in April 2022 priced at $12. It did rise to $15.21, but, subsequently,…